Tree News · 2026-11-15 12:00 UTC

SUMMIT THERAPEUTICS - FDA CANNOT APPROVE IVONESCIMAB BLA DUE TO LACK OF STATISTICALLY SIGNIFICANT OS IMPROVEMENT

Loading the story on Tree News…